Relationship between peripheral B cell return and loss of EULAR response in RA patients treated with rituximab.

被引：0
|
作者：
Emery, P.
Breedveld, F.
Martin-Mola, E.
Pavelka, K.
Szczepanski, L.
Kim, D.
Magrini, F.
Behrendt, C.
Kelman, A.
机构：
[1] Leeds Gen Infirm, Leeds, W Yorkshire, England
[2] Leiden Univ, Leiden, Netherlands
[3] Hosp Univ La Paz, Madrid, Spain
[4] Inst Rheumatol, Prague, Czech Republic
[5] Tech Univ Lublin, PL-20618 Lublin, Poland
[6] Biogen Idec, San Diego, CA USA
[7] Roche Prod Ltd, Welwyn Garden City AL7 3AY, Herts, England
[8] Genentech Inc, San Francisco, CA 94080 USA
来源：
ARTHRITIS AND RHEUMATISM | 2006年 / 54卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S66 / S66
页数：1
相关论文
共 50 条
  • [31] Highly sensitive B cell analysis predicts response to rituximab therapy in RA.
    Dass, S.
    Rawstron, A. C.
    Vital, E. M.
    Jain, S.
    Bingham, S. J.
    McGonagle, D.
    Emery, P.
    [J]. ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S832 - S832
  • [32] ANTI-CCP IS AN INDEPENDENT PREDICTOR OF 12-MONTH EULAR RESPONSE IN PATIENTS WITH RA TREATED WITH ABATACEPT
    den Broeder, A.
    Kerstens, T.
    Fransen, J.
    van den Ende, C.
    Tweehuysen, L.
    Postema, R.
    Alemao, E.
    van den Hoogen, F.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 568 - 568
  • [33] Treatment of diffuse large B cell lymphoma with CHOP and rituximab.: Results of a multicenter study with 236 patients.
    De la Serna, J
    Ayala, R
    Canales, M
    Giraldo, P
    de la Cruz-Mora, M
    Rueda, A
    Montalban, C
    Queizan, J
    Garcia-Vela, J
    Feliu, F
    Calle, C
    Hernandez, B
    Hernandez, R
    Solano, F
    Peñalver, J
    Ojanguren, J
    Sanchez-Guilarte, J
    Morante, C
    Nicolas, C
    Roman, A
    Palomera, L
    Diaz-Mediavilla, J
    [J]. BLOOD, 2005, 106 (11) : 264B - 264B
  • [34] IN RA PATIENTS WITH INITIAL RESPONSE TO RITUXIMAB, EARLY DEPTH OF B CELL DEPLETION IS ASSOCIATED WITH LONG TERM MAINTENANCE OF THERAPY
    Montoya, L. Garcia
    Yusof, M. Y. Md
    Candelier, J. -B.
    Pentony, P.
    Duquenne, L.
    Rawstron, A. C.
    Vital, E. M.
    Emery, P.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 104 - 105
  • [35] TRANSITIONAL AND MEMORY B CELL ANALYSIS IS AN ESSENTIAL TOOL TO ANTICIPATE CLINICAL RELAPSE IN RHEUMATOID ARTHRITIS (RA) PATIENTS TREATED WITH RITUXIMAB
    Trouvin, A. -P.
    Jacquot, S.
    Grigioni, S.
    Boulard, H.
    Dutot, I.
    Vittecoq, O.
    Le Loet, X.
    Boyer, O.
    Goeb, V.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 446 - 446
  • [36] Treatment of RA with rituximab leads to selected peripheral B-cell depletion with minimal effect on immunoglobulins
    Szechinski, J
    Szczepanski, L
    Filipowicz-Sosnowska, A
    Stahj, HD
    Edwards, JCW
    Close, DR
    Stevens, R
    Shaw, TW
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 171 - 171
  • [37] Analysis of prognostic factors and pharmacodynamic parameters in relapsed indolent B-NHL and mantle cell lymphoma (MCL) treated with rituximab.
    Tobinai, K
    Igarashi, T
    Ogura, M
    Kinoshita, T
    Kobayashi, Y
    Sasaki, Y
    Morishima, Y
    Uike, N
    Taniwaki, M
    Kano, Y
    Kasai, M
    Ohnishi, K
    [J]. BLOOD, 2000, 96 (11) : 249B - 249B
  • [38] Total serum immunoglobulin levels in patients with RA after multiple B-cell depletion cycles based on rituximab: relationship with B-cell kinetics
    De La Torre, Inmaculada
    Leandro, Maria J.
    Valor, Lara
    Becerra, Elena
    Edwards, Jonathan C. W.
    Cambridge, Geraldine
    [J]. RHEUMATOLOGY, 2012, 51 (05) : 833 - 840
  • [39] Severe side effects in patients with B-cell chronic lymphocytic leukemia (CLL) and lymphocytosis treated with the monoclonal anti-CD20 antibody rituximab.
    Winkler, U
    Jensen, M
    Manzke, O
    Tesch, H
    Bohlen, H
    Diehl, V
    Engert, A
    [J]. BLOOD, 1998, 92 (10) : 285B - 285B
  • [40] RELATION OF SUBCLINICAL ULTRASOUND DETECTED SYNOVITIS AND PERIPHERAL B-CELL COUNTS IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH RITUXIMAB
    Estupinan, L. P. Martinez
    Naredo, E.
    Valor, L.
    Janta, I.
    Montoro, M.
    Del Rio, T.
    Nieto-Gonzalez, J. C.
    Hinojosa, M.
    Bello, N.
    Martinez, J.
    Gonzalez-Fernandez, C.
    Lopez-Longo, J.
    Monteagudo, I.
    Carreno-Perez, L.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 951 - 951
12345